Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.45 CAD
-0.09 (-0.42%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CHR scores 4 out of 10 in our fundamental rating. CHR was compared to 5 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
In the past year CHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
In the past 5 years CHR always reported a positive cash flow from operatings.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CHR (-2.62%) is worse than 60.00% of its industry peers.
The Return On Equity of CHR (-6.31%) is better than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.40%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 3.84%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a Operating Margin of 6.81%. This is in the better half of the industry: CHR outperforms 80.00% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.68%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR is destroying value.
CHR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CHR has been increased compared to 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR has an Altman-Z score of 0.90. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
CHR has a Altman-Z score of 0.90. This is comparable to the rest of the industry: CHR outperforms 60.00% of its industry peers.
The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 10.63, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, CHR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.9
ROIC/WACC0.79
WACC8.1%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
CHR has a Current ratio (1.22) which is comparable to the rest of the industry.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHR (0.63) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
Looking at the last year, CHR shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
CHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

CHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
The Revenue is expected to decrease by -4.52% on average over the next years.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.83, the valuation of CHR can be described as very reasonable.
100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
CHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
With a Price/Forward Earnings ratio of 10.91, the valuation of CHR can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR indicates a somewhat cheap valuation: CHR is cheaper than 80.00% of the companies listed in the same industry.
CHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 8.83
Fwd PE 10.91
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

80.00% of the companies in the same industry are more expensive than CHR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.46
EV/EBITDA 3.9
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHR's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.51%. Purely for dividend investing, there may be better candidates out there.
CHR's Dividend Yield is a higher than the industry average which is at 0.96.
Compared to the average S&P500 Dividend Yield of 2.00, CHR is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

The dividend of CHR is nicely growing with an annual growth rate of 21.58%!
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
CHR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (12/31/2025, 7:00:00 PM)

21.45

-0.09 (-0.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.79%
Inst Owner ChangeN/A
Ins Owners1.48%
Ins Owner ChangeN/A
Market Cap502.36M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78
Price Target30.26 (41.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)4.04%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)-1.68%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 8.83
Fwd PE 10.91
P/S 0.37
P/FCF 15.46
P/OCF 7.05
P/B 0.91
P/tB 0.92
EV/EBITDA 3.9
EPS(TTM)2.43
EY11.33%
EPS(NY)1.97
Fwd EY9.17%
FCF(TTM)1.39
FCFY6.47%
OCF(TTM)3.04
OCFY14.17%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.9
F-Score6
WACC8.1%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.83 and the Price/Book (PB) ratio is 0.91.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.